Part Three: Setting a Standard for GP Compliance
A recent article series by Huron Managing Director Chris Cobourn is designed to help life sciences compliance professionals understand the complex, and sometimes contradictory, universes of publicly funded health programs.
Examining programs from a manufacturer perspective, the three-part series was originally published in Life Science Compliance Update, and each part will be republished on Huron's website over the next two weeks.
Part 1 - An overview of the publicly funded programs and the populations they serve
Part 2 - The operational requirements of the programs for drug manufacturers in the U.S.
Part 3 - How to evaluate a company’s compliance with the programs
For more information about compliance implications of the AMP’s Final Rule, you can contact Huron by visiting our landing page. You can also hear more from Huron on this issue by following @Huron for up-to-date webinars, events, and speaking engagements.Read More
Subscribe to Huron Insights
Sign Up to get all of the great Huron insights.Newsletter Subscriptions